APA (7th ed.) Citation

Soria, J. C., Gan, H. K., Blagden, S. P., Plummer, R., Arkenau, H. T., Ranson, M., . . . Auger, K. R. (2016). A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors. Annals of Oncology, 27(12), 2268. https://doi.org/10.1093/annonc/mdw427

Chicago Style (17th ed.) Citation

Soria, J. C., et al. "A Phase I, Pharmacokinetic and Pharmacodynamic Study of GSK2256098, a Focal Adhesion Kinase Inhibitor, in Patients with Advanced Solid Tumors." Annals of Oncology 27, no. 12 (2016): 2268. https://doi.org/10.1093/annonc/mdw427.

MLA (9th ed.) Citation

Soria, J. C., et al. "A Phase I, Pharmacokinetic and Pharmacodynamic Study of GSK2256098, a Focal Adhesion Kinase Inhibitor, in Patients with Advanced Solid Tumors." Annals of Oncology, vol. 27, no. 12, 2016, p. 2268, https://doi.org/10.1093/annonc/mdw427.